What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 3.7% in the pre-market session after analysts at ...

In a market dominated by headlines about artificial intelligence (AI), cloud computing, and digital platforms, it is easy to ...

According to the Adhishthana Principles, Illumina stock may remain under pressure for over 18 years — here's why.

CorMedix (CRMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Illumina (NASDAQ:ILMN – Get Free Report) had its price target dropped by Morgan Stanley from $136.00 to $100.00 in a research report issued on Monday,Benzinga reports. The firm currently has an ...

Illumina (NASDAQ:ILMN) shares slipped in the morning hours on Wednesday after Citi downgraded its stock to Sell from Neutral, arguing that the firm’s bearish views don’t support the recent ...

Illumina (NASDAQ:ILMN) stock dips as Scotiabank downgrades. However, peers Danaher (DHR) stock and Thermo Fisher (TMO) stock win upgrades. Read more here.

Barclays lowered their target price on Illumina from $100.00 to $77.00 and set an “underweight” rating on the stock in a report on Thursday, April 10th.

Shares of Illumina Inc. ILMN advanced 1.00% to $91.52 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.11% to 6,092.18 ...

Shares of Illumina Inc. ILMN slid 1.40% to $81.09 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.41% to 5,935.94 and the ...

Illumina’s Q1 Revenues Revenues amounted to $1.04 billion, down 1.4% year over year and flat on a constant-currency basis. However, the top line beat the Zacks Consensus Estimate by 0.2% ...